PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 28, 2026Dermatologic Therapy0 citationsOpen Access

A Prospective Study Evaluating the Prevalence of Arthralgia and Other Inflammatory Comorbidities Among Hidradenitis Suppurativa Patients

View Full Paper
TTTuğba TehçiEKEmrah KoçDÖDefne Özkoca

Key Points

  • This study aims to evaluate the prevalence of arthralgia and associated inflammatory comorbidities in patients with hidradenitis suppurativa.
  • Prospective study with 64 HS patients conducted at Adana City Hospital between December 2023 and December 2024.
  • Assessment of demographics, disease severity using Hurley staging, comorbidities, and treatment history.
  • Statistical analysis of the relationship between arthralgia and clinical variables using SPSS v21.
  • Arthralgia reported in 56.3% of patients, and spondyloarthropathy diagnosed in 17.2%.
  • Increasing age significantly associated with arthralgia (p = 0.005).
  • No significant association between arthralgia and disease severity, smoking, vitamin D deficiency, obesity, or previous treatments.

Abstract

Background Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease associated with significant morbidity and a reduction in the quality of life. Recent studies report an increased prevalence of systemic inflammatory comorbidities, including arthralgia and spondyloarthropathy (SA), among HS patients. However, the factors contributing to these associations remain poorly understood. Methods This prospective study includes 64 patients diagnosed with HS at Adana City Hospital between December 2023 and December 2024. Demographics, disease severity (Hurley staging), comorbid conditions, and treatment history of each patient were noted. Patients reporting joint pain or back pain were evaluated by a rheumatologist and underwent additional laboratory and radiological investigations accordingly. The relationship between arthralgia and clinical variables was statistically analyzed using SPSS v21. Results The mean age of the participants was 31.78 years. Arthralgia was reported in 56.3% of patients, and SA was diagnosed in 17.2% of the total cohort. The presence of arthralgia was found to be independent of the Hurley stage ( p = 0.998), smoking ( p = 0.765), vitamin D deficiency ( p = 0.971), obesity ( p = 0.974), or previous systemic treatments, including anti‐TNF agents ( p = 0.054). However, increasing age was significantly associated with arthralgia ( p = 0.005). Common comorbidities included obesity (39.1%), diabetes (25%), hypertension (14.1%), and acneiform eruptions (28.1%). Conclusions Arthralgia is a frequent and often underrecognized comorbidity in HS patients, and it is independent of disease severity or treatment history. Increasing age is a significant risk factor. Our findings support the need for routine screening for musculoskeletal symptoms in HS patients and closer interdisciplinary collaboration with rheumatology.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Tehçi et al. (2026) studied this question.

synapsesocial.com/papers/69f04e5b727298f751e72492https://doi.org/10.1155/dth/4499864
Ask AI
Helpful
Bookmark
Share
View Full Paper